Sophie Hans

668 total citations
8 papers, 337 citations indexed

About

Sophie Hans is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sophie Hans has authored 8 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Immunology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sophie Hans's work include Cancer Immunotherapy and Biomarkers (7 papers), Renal cell carcinoma treatment (2 papers) and CAR-T cell therapy research (2 papers). Sophie Hans is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Renal cell carcinoma treatment (2 papers) and CAR-T cell therapy research (2 papers). Sophie Hans collaborates with scholars based in France, United States and Austria. Sophie Hans's co-authors include Éric Tartour, Clémence Granier, Charlotte Blanc, Fathia Mami‐Chouaib, Stéphanie Corgnac, Ines Malenica, Stéphane Oudard, Marie Anson, Thi Tran and Laurent Dercle and has published in prestigious journals such as Chemistry of Materials, Radiology and Annals of Oncology.

In The Last Decade

Sophie Hans

8 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sophie Hans France	6	217	199	62	56	39	8	337
Yuki Muroyama United States	5	241 1.1×	181 0.9×	52 0.8×	50 0.9×	30 0.8×	10	330
Wendy Mao United States	5	226 1.0×	181 0.9×	81 1.3×	97 1.7×	40 1.0×	8	342
Zsolt Sebestyén Hungary	4	197 0.9×	221 1.1×	66 1.1×	45 0.8×	39 1.0×	15	380
Koji Nagaoka Japan	12	241 1.1×	228 1.1×	59 1.0×	122 2.2×	34 0.9×	27	385
Ming Gu China	7	250 1.2×	206 1.0×	46 0.7×	84 1.5×	27 0.7×	12	381
Ines Malenica France	6	222 1.0×	201 1.0×	53 0.9×	82 1.5×	43 1.1×	8	354
Mei Cao China	8	160 0.7×	122 0.6×	71 1.1×	89 1.6×	85 2.2×	15	321
Justin M. Asquith United States	4	243 1.1×	241 1.2×	36 0.6×	108 1.9×	36 0.9×	7	350
Carla Costa-Nunes Switzerland	3	381 1.8×	368 1.8×	44 0.7×	87 1.6×	33 0.8×	3	483

Countries citing papers authored by Sophie Hans

Since Specialization

Citations

This map shows the geographic impact of Sophie Hans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Hans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Hans more than expected).

Fields of papers citing papers by Sophie Hans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Hans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Hans. The network helps show where Sophie Hans may publish in the future.

Co-authorship network of co-authors of Sophie Hans

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Hans. A scholar is included among the top collaborators of Sophie Hans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Hans. Sophie Hans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Dercle, Laurent, Samy Ammari, Elvire Roblin, et al.. (2022). High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy. European Journal of Cancer. 177. 80–93. 20 indexed citations

2.

Dercle, Laurent, Shawn Sun, Romain‐David Seban, et al.. (2022). Emerging and Evolving Concepts in Cancer Immunotherapy Imaging. Radiology. 306(1). 32–46. 31 indexed citations

3.

Vano, Yann, Gwénaëlle Gravis, Friederike Schlürmann, et al.. (2022). Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study. International Journal of Cancer. 151(8). 1335–1344. 6 indexed citations

4.

Cao, Yidan, Sophie Hans, Ulrike Werner‐Zwanziger, et al.. (2021). Si(CO)_y Negative Electrodes for Li-Ion Batteries. Chemistry of Materials. 33(18). 7386–7395. 9 indexed citations

5.

Hans, Sophie, Laurent Dercle, Stéphane Champiat, et al.. (2019). Sarcoidosis-like reaction mimics progression in patients treated with immune checkpoint inhibitors. Annals of Oncology. 30. v529–v530. 2 indexed citations

6.

Hans, Sophie, Audrey Simonaggio, Laure Fournier, et al.. (2019). Nivolumab (N) treatment beyond progression in a real-world cohort of patients (pts) with metastatic renal cell carcinoma (mRCC). Annals of Oncology. 30. v388–v389. 1 indexed citations

7.

Blanc, Charlotte, Sophie Hans, Thi Tran, et al.. (2018). Targeting Resident Memory T Cells for Cancer Immunotherapy. Frontiers in Immunology. 9. 1722–1722. 49 indexed citations

8.

Mami‐Chouaib, Fathia, Charlotte Blanc, Stéphanie Corgnac, et al.. (2018). Resident memory T cells, critical components in tumor immunology. Journal for ImmunoTherapy of Cancer. 6(1). 87–87. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact